person · Reporting owner
Cooperatieve Gilde Healthcare IV U.A.
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Axonics, Inc.
Report date November 21, 2019 · Filed December 10, 2019
Jointly reported with Gilde Healthcare Holding B.V., Gilde Healthcare IV Management B.V.
Section 16 reporting ended · disclosed 2019-12-10. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Inari Medical, Inc.
Report date March 12, 2021 · Filed March 16, 2021
Jointly reported with Gilde Healthcare IV Management B.V., Gilde Healthcare Holding B.V.
Section 16 reporting ended · disclosed 2021-03-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 4,491,679 |
Last balance in matching sequence
After 2021-03-15 transaction · row 13
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
13 source rowsRow 1 · 2021-03-12 · Sale · Disposed 47,935 · Balance 5,893,744 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $114.45 to $115.44, inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 2 · 2021-03-12 · Sale · Disposed 113,990 · Balance 5,779,754 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $115.45 to $116.44, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 3 · 2021-03-12 · Sale · Disposed 32,926 · Balance 5,746,828 F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $116.45 to $117.445, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 4 · 2021-03-12 · Sale · Disposed 18,700 · Balance 5,728,128 F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $117.45 to $118.40, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 5 · 2021-03-12 · Sale · Disposed 24,689 · Balance 5,703,439 F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $118.47 to $119.42, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 6 · 2021-03-12 · Sale · Disposed 11,760 · Balance 5,691,679 F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $119.575 to $120.00, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 7 · 2021-03-15 · Sale · Disposed 4,707 · Balance 5,686,972 F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $112.655 to $113.63, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 8 · 2021-03-15 · Sale · Disposed 89,169 · Balance 5,597,803 F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $113.67 to $114.665, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 9 · 2021-03-15 · Sale · Disposed 49,316 · Balance 5,548,487 F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $114.6775 to $115.66, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 10 · 2021-03-15 · Sale · Disposed 33,799 · Balance 5,514,688 F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $115.67 to $116.66, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 11 · 2021-03-15 · Sale · Disposed 20,663 · Balance 5,494,025 F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $116.67 to $117.61, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 12 · 2021-03-15 · Sale · Disposed 2,346 · Balance 5,491,679 F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $117.71 to $118.31, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 13 · 2021-03-15 · Sale · Disposed 1,000,000 · Balance 4,491,679 F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $114.45 to $115.44, inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $115.45 to $116.44, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $116.45 to $117.445, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $117.45 to $118.40, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $118.47 to $119.42, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $119.575 to $120.00, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $112.655 to $113.63, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $113.67 to $114.665, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $114.6775 to $115.66, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $115.67 to $116.66, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $116.67 to $117.61, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $117.71 to $118.31, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
LAVA Therapeutics NV
Report date October 16, 2025 · Filed October 20, 2025
Jointly reported with Gilde Healthcare Holding B.V.
Section 16 reporting ended · disclosed 2025-10-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 4,128,912 |
Reported balance
After 2025-10-16 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-10-16 · Sale · Disposed 690,239 · Balance 4,128,912 F1: This figure is the weighted average sales price of multiple trades ranging from $1.47 to $1.53 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. |
| Common SharesSEC Table I · non-derivative | Direct | 2,947,781 |
Reported balance
After 2025-10-17 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2025-10-17 · Sale · Disposed 1,181,131 · Balance 2,947,781 F3: This figure is the weighted average sales price of multiple trades ranging from $1.44 to $1.52 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. |
| Common SharesSEC Table I · non-derivative | Direct | 1,947,781 |
Reported balance
After 2015-10-20 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2015-10-20 · Sale · Disposed 1,000,000 · Balance 1,947,781 F4: This figure is the weighted average sales price of multiple trades ranging from $1.44 to $1.51 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. |
Filing footnotes · ownership attribution and instrument terms
F1: This figure is the weighted average sales price of multiple trades ranging from $1.47 to $1.53 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
F2: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein.
F3: This figure is the weighted average sales price of multiple trades ranging from $1.44 to $1.52 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
F4: This figure is the weighted average sales price of multiple trades ranging from $1.44 to $1.51 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 17, 2025 Filed Oct 20, 2025 22:58 UTC | LAVA Therapeutics NV LVTX · Entity 73047 | SaleCommon Shares | 1,181,131 | $1.47 | $1,736,262.57 |
DisclosureSEC source: 0001193125-25-243899 · ownership.xml · nonDerivative · entry 2 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,947,781 F3 · price: This figure is the weighted average sales price of multiple trades ranging from $1.44 to $1.52 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2 · ownership.direct: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 22:58 UTC | LAVA Therapeutics NV LVTX · Entity 73047 | SaleCommon Shares | 690,239 | $1.49 | $1,028,456.11 |
DisclosureSEC source: 0001193125-25-243899 · ownership.xml · nonDerivative · entry 1 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,128,912 F1 · price: This figure is the weighted average sales price of multiple trades ranging from $1.47 to $1.53 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2 · ownership.direct: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. Read SEC document |
| October 14, 2025 Filed Oct 16, 2025 00:56 UTC | LAVA Therapeutics NV LVTX · Entity 73047 | SaleCommon Shares | 227,341 | $1.51 | $343,284.91 |
DisclosureSEC source: 0001193125-25-240610 · ownership.xml · nonDerivative · entry 2 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,019,151 F3 · price: This figure is the weighted average sales price of multiple trades ranging from $1.50 to $1.55 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2 · ownership.direct: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. Read SEC document |
| October 13, 2025 Filed Oct 16, 2025 00:56 UTC | LAVA Therapeutics NV LVTX · Entity 73047 | SaleCommon Shares | 47,686 | $1.54 | $73,436.44 |
DisclosureSEC source: 0001193125-25-240610 · ownership.xml · nonDerivative · entry 1 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,246,492 F1 · price: This figure is the weighted average sales price of multiple trades ranging from $1.53 to $1.55 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2 · ownership.direct: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. Read SEC document |
| October 10, 2025 Filed Oct 10, 2025 22:45 UTC | LAVA Therapeutics NV LVTX · Entity 73047 | SaleCommon Shares | 49,869 | $1.55 | $77,296.95 |
DisclosureSEC source: 0001193125-25-237275 · ownership.xml · nonDerivative · entry 3 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,294,178 F4 · price: This figure is the weighted average sales price of multiple trades ranging from $1.53 to $1.58 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2 · ownership.direct: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 22:45 UTC | LAVA Therapeutics NV LVTX · Entity 73047 | SaleCommon Shares | 48,169 | $1.56 | $75,143.64 |
DisclosureSEC source: 0001193125-25-237275 · ownership.xml · nonDerivative · entry 2 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,344,047 F3 · price: This figure is the weighted average sales price of multiple trades ranging from $1.54 to $1.59 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2 · ownership.direct: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 22:45 UTC | LAVA Therapeutics NV LVTX · Entity 73047 | SaleCommon Shares | 28,954 | $1.57 | $45,457.78 |
DisclosureSEC source: 0001193125-25-237275 · ownership.xml · nonDerivative · entry 1 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,392,216 F1 · price: This figure is the weighted average sales price of multiple trades ranging from $1.56 to $1.62 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2 · ownership.direct: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 1,000,000 | $111.50 | $111,500,000.00 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 13 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,491,679 F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 2,346 | $117.98 | $276,781.08 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 12 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,491,679 F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $117.71 to $118.31, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 20,663 | $116.96 | $2,416,744.48 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 11 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,494,025 F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $116.67 to $117.61, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 33,799 | $116.17 | $3,926,429.83 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 10 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,514,688 F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $115.67 to $116.66, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 49,316 | $115.15 | $5,678,737.40 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 9 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,548,487 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $114.6775 to $115.66, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 89,169 | $114.22 | $10,184,883.18 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 8 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,597,803 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $113.67 to $114.665, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 4,707 | $113.21 | $532,879.47 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 7 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,686,972 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $112.655 to $113.63, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 11,760 | $119.81 | $1,408,965.60 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 6 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,691,679 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $119.575 to $120.00, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 24,689 | $119.01 | $2,938,237.89 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 5 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,703,439 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $118.47 to $119.42, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 18,700 | $117.86 | $2,203,982.00 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 4 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,728,128 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $117.45 to $118.40, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 32,926 | $116.92 | $3,849,707.92 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 3 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,746,828 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $116.45 to $117.445, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 113,990 | $115.84 | $13,204,601.60 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 2 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,779,754 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $115.45 to $116.44, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 47,935 | $115.15 | $5,519,715.25 |
DisclosureSEC source: 0000899243-21-011924 · doc4.xml · nonDerivative · entry 1 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,893,744 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $114.45 to $115.44, inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 1,947 | $83.47 | $162,516.09 |
DisclosureSEC source: 0000899243-20-035182 · doc4.xml · nonDerivative · entry 10 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,941,679 F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $83.325 to $83.62, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 8,830 | $82.64 | $729,711.20 |
DisclosureSEC source: 0000899243-20-035182 · doc4.xml · nonDerivative · entry 9 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,943,626 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $82.205 to $83.19, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 22,439 | $81.73 | $1,833,939.47 |
DisclosureSEC source: 0000899243-20-035182 · doc4.xml · nonDerivative · entry 8 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,952,456 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $81.19 to $82.16, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 5,852 | $80.79 | $472,783.08 |
DisclosureSEC source: 0000899243-20-035182 · doc4.xml · nonDerivative · entry 7 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,974,895 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $80.13 to $81.12, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 1,208 | $84.27 | $101,798.16 |
DisclosureSEC source: 0000899243-20-035182 · doc4.xml · nonDerivative · entry 6 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,980,747 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $84.09 to $84.91, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 2,234 | $83.40 | $186,315.60 |
DisclosureSEC source: 0000899243-20-035182 · doc4.xml · nonDerivative · entry 5 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,981,955 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $82.91 to $83.79, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 8,926 | $82.04 | $732,289.04 |
DisclosureSEC source: 0000899243-20-035182 · doc4.xml · nonDerivative · entry 4 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,984,189 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $81.90 to $82.88, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 42,643 | $81.36 | $3,469,434.48 |
DisclosureSEC source: 0000899243-20-035182 · doc4.xml · nonDerivative · entry 3 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,993,115 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $80.925 to $81.88, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 164,392 | $80.45 | $13,225,336.40 |
DisclosureSEC source: 0000899243-20-035182 · doc4.xml · nonDerivative · entry 2 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,035,758 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $79.925 to $80.92, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 16:05 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 46,365 | $79.51 | $3,686,481.15 |
DisclosureSEC source: 0000899243-20-035182 · doc4.xml · nonDerivative · entry 1 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,200,150 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $78.90 to $79.895, inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 28,700 | $78.31 | $2,247,497.00 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 17 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,246,515 F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $78.00 to $78.81, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 6,316 | $77.79 | $491,321.64 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 16 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,275,215 F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $77.67 to $77.995, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 43,841 | $77.22 | $3,385,402.02 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 15 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,281,531 F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $76.6675 to $77.665, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 5,287 | $76.12 | $402,446.44 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 14 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,325,372 F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $75.645 to $76.625, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 4,714 | $74.48 | $351,098.72 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 13 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,330,659 F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $74.09 to $74.71, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 4,880 | $78.57 | $383,421.60 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 12 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,335,373 F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $78.51 to $78.68, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 98,190 | $78.21 | $7,679,439.90 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 11 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,340,253 F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $77.605 to $78.50, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 71,340 | $77.22 | $5,508,874.80 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 10 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,438,443 F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $76.605 to $77.60, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 20,754 | $76.11 | $1,579,586.94 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 9 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,509,783 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $75.605 to $76.59, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 44,268 | $74.53 | $3,299,294.04 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 8 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,530,537 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $74.00 to $74.795, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 71,415 | $73.47 | $5,246,860.05 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 7 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,574,805 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $73.00 to $73.99, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 54,257 | $72.47 | $3,932,004.79 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 6 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,646,220 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $72.00 to $72.995, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 13,125 | $71.73 | $941,456.25 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 5 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,700,477 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $71.00 to $71.995, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 11,885 | $70.41 | $836,822.85 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 4 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,713,602 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.885, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 41,878 | $72.16 | $3,021,916.48 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 3 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,725,487 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $72.00 to $72.435, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 110,474 | $71.53 | $7,902,205.22 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 2 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,767,365 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $71.00 to $71.995, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 19:29 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 63,840 | $70.52 | $4,501,996.80 |
DisclosureSEC source: 0000899243-20-034885 · doc4.xml · nonDerivative · entry 1 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,877,839 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.995 inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 17:22 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 5,075 | $67.39 | $342,004.25 |
DisclosureSEC source: 0000899243-20-033761 · doc4.xml · nonDerivative · entry 5 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,941,679 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.105 to $67.55, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 17:22 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 66,371 | $66.60 | $4,420,308.60 |
DisclosureSEC source: 0000899243-20-033761 · doc4.xml · nonDerivative · entry 4 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,946,754 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.11 to $67.09, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 17:22 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 98,180 | $68.22 | $6,697,839.60 |
DisclosureSEC source: 0000899243-20-033761 · doc4.xml · nonDerivative · entry 3 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,013,125 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.005 to $68.56, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.